yingweiwo

Histidine

Alias: Histidine NSC137773 NSC 137773 NSC-137773L-Histidine
Cat No.:V7857 Purity: ≥98%
L-Histidine is an essential amino acid (AA) for babies.
Histidine
Histidine Chemical Structure CAS No.: 71-00-1
Product category: New1
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
1g
Other Sizes

Other Forms of Histidine:

  • L-Histidine-15N3
  • L-Histidine dihydrochloride (histidine hydrochloride)
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Top Publications Citing lnvivochem Products
Product Description
L-Histidine is an essential amino acid (AA) for babies. L-Histidine is an inhibitor (blocker/antagonist) of mitochondrial glutamine transport.
Biological Activity I Assay Protocols (From Reference)
ln Vitro
Growth was totally suppressed by L-histidine, and its impact on viability was inversely connected with the expression of FLO11. L-histidine had no effect on the S288c and Δflo11 strains' capacity to survive. Saccharomyces floresii's air-liquid biofilm formation and polysiloxane traces were greatly inhibited by L-histidine, while the altered levels of the FLO11 gene remained unaffected. Moreover, L-histidine can alter the amount of lipid and chitin in the flor yeast cell wall [1].
ln Vivo
Brain edema treated with thioacetamide is completely inhibited by L-histidine (100 mg/kg) [2]. 60% of the cerebral edema in the L-histidine diet group was caused by the histamine release in the hypothalamus under strong K+ stimulation. The L-histidine diet, however, has no effect on other monoamines and does not change the substance's concentration. While the L-histidine diet group stopped in the light box during their entire stay in the light/dark box test performance, they stopped in the center zone during the open field test performance. This suggests that the L-histidine diet group may cause anxiety-like behavior [3].
ADME/Pharmacokinetics
Absorption, Distribution and Excretion
Absorbed from the small intestine via an active transport mechanism requiring the presence of sodium.
ESSENTIAL AMINO ACIDS ARE TRANSFERRED TO FETUS AGAINST A CONCN GRADIENT &, IN THE CASE OF HISTIDINE, NATURAL L-ISOMER HAS BEEN SHOWN TO CROSS SEVERAL TIMES AS FAST AS THE D-ISOMER.
Metabolism / Metabolites
PRODUCT OF OXIDATIVE DEAMINATION OR TRANSAMINATION OF L-HISTIDINE IS BETA-IMIDAZOLEPYRUVIC ACID; & PRODUCT OF DECARBOXYLATION IS HISTAMINE. HISTAMINE ENTERS OTHER PATHWAYS TO YIELD FURTHER METABOLIC PRODUCTS. /FROM TABLE/
Toxicity/Toxicokinetics
Toxicity Summary
Since the actions of supplemental L-histidine are unclear, any postulated mechanism is entirely speculative. However, some facts are known about L-histidine and some of its metabolites, such as histamine and trans-urocanic acid, which suggest that supplemental L-histidine may one day be shown to have immunomodulatory and/or antioxidant activities. Low free histidine has been found in the serum of some rheumatoid arthritis patients. Serum concentrations of other amino acids have been found to be normal in these patients. L-histidine is an excellent chelating agent for such metals as copper, iron and zinc. Copper and iron participate in a reaction (Fenton reaction) that generates potent reactive oxygen species that could be destructive to tissues, including joints.
L-histidine is the obligate precursor of histamine, which is produced via the decarboxylation of the amino acid. In experimental animals, tissue histamine levels increase as the amount of dietary L-histidine increases. It is likely that this would be the case in humans as well. Histamine is known to possess immunomodulatory and antioxidant activity. Suppressor T cells have H2 receptors, and histamine activates them. Promotion of suppressor T cell activity could be beneficial in rheumatoid arthritis. Further, histamine has been shown to down-regulate the production of reactive oxygen species in phagocytic cells, such as monocytes, by binding to the H2 receptors on these cells. Decreased reactive oxygen species production by phagocytes could play antioxidant, anti-inflammatory and immunomodulatory roles in such diseases as rheumatoid arthritis.
This latter mechanism is the rationale for the use of histamine itself in several clinical trials studying histamine for the treatment of certain types of cancer and viral diseases. In these trials, down-regulation by histamine of reactive oxygen species formation appears to inhibit the suppression of natural killer (NK) cells and cytotoxic T lymphocytes, allowing these cells to be more effective in attacking cancer cells and virally infected cells.
Toxicity Data
ORL-RAT LD50 > 15000 mg/kg, IPR-RAT LD50 > 8000 mg/kg, ORL-MUS LD50 > 15000 mg/kg, IVN-MUS LD50 > 2000 mg/kg
Interactions
WARFARIN ALONE AT 5 MG/KG OF BAIT KILLED 37% OF ROOF RATS, BUT WHEN IN COMBINATION WITH L-HISTIDINE (40 MG/KG BAIT), ACTIVATED CLAY, CHARCOAL, & CARBON (10 G/KG BAIT) IT CAUSED, RESPECTIVELY, 100, 88, 75, & 63% MORTALITY OF RATS.
References
[1]. Bou Zeidan M, et al. L-histidine inhibits biofilm formation and FLO11-associated phenotypes in Saccharomyces cerevisiae flor yeasts. PLoS One. 2014 Nov 4;9(11):e112141.
[2]. Rama Rao KV, et al. Brain edema in acute liver failure: inhibition by L-histidine. Am J Pathol. 2010 Mar;176(3):1400-8.
[3]. Yoshikawa T, et al. Insufficient intake of L-histidine reduces brain histamine and causes anxiety-like behaviors in male mice. J Nutr. 2014 Oct;144(10):1637-41
Additional Infomation
Pharmacodynamics
Is found abundantly in hemoglobin; has been used in the treatment of rheumatoid arthritis, allergic diseases, ulcers and anemia. A deficiency can cause poor hearing.
These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C6H9N3O2
Molecular Weight
155.15
Exact Mass
155.069
CAS #
71-00-1
Related CAS #
L-Histidine-15N3;1217456-12-6;L-Histidine-13C6,15N3 hydrochloride;L-Histidine dihydrochloride;6027-02-7
PubChem CID
6274
Appearance
Needles or plates
COLORLESS
Density
1.4±0.1 g/cm3
Boiling Point
458.9±35.0 °C at 760 mmHg
Melting Point
282 °C (dec.)(lit.)
Flash Point
231.3±25.9 °C
Vapour Pressure
0.0±1.2 mmHg at 25°C
Index of Refraction
1.615
LogP
-1.26
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
4
Rotatable Bond Count
3
Heavy Atom Count
11
Complexity
151
Defined Atom Stereocenter Count
1
SMILES
C1=C(NC=N1)C[C@@H](C(=O)O)N
InChi Key
HNDVDQJCIGZPNO-YFKPBYRVSA-N
InChi Code
InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1
Chemical Name
(2S)-2-amino-3-(1H-imidazol-5-yl)propanoic acid
Synonyms
Histidine NSC137773 NSC 137773 NSC-137773L-Histidine
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
H2O : ~20.83 mg/mL (~134.26 mM)
DMSO : ~1 mg/mL (~6.45 mM)
Solubility (In Vivo)
Solubility in Formulation 1: 25 mg/mL (161.13 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 6.4454 mL 32.2269 mL 64.4538 mL
5 mM 1.2891 mL 6.4454 mL 12.8908 mL
10 mM 0.6445 mL 3.2227 mL 6.4454 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Clinical Trial Information
NCT Number Recruitment interventions Conditions Sponsor/Collaborators Start Date Phases
NCT04142294 COMPLETED Dietary Supplement: Histidine Healthy Cornell University 2017-09-21 Not Applicable
NCT02924935 UNKNOWN STATUS Dietary Supplement: L-Histidine HARS Syndrome Lawson Health Research Institute 2018-08-01 Phase 2
Phase 3
NCT06169826 NOT YET RECRUITING Drug: l-Histidine
Other: Control
Alzheimer Disease Wake Forest University Health Sciences 2024-09 Phase 4
NCT00001262 COMPLETEDWITH RESULTS Drug: Copper Histidine Kinky Hair Syndrome Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 1990-06 Phase 1
Phase 2
NCT05562310 RECRUITING Drug: Total parenteral nutrition (TPN).
This is total nutrition provided by central vein.
Receiving Total Parenteral Nutrition (TPN) Stable Neonates The Hospital for Sick Children 2023-04-02 Not Applicable
Biological Data
  • High throughput and cluster analysis of nitrogen metabolism of different S. cerevisiae strains. The nitrogen uptake of the A9, M23, V80 and S288c strains was measured using the phenotype microarray technique. (A) Cluster analysis (Pearson coefficient, UPGMA) for similarity regrouping of tested strains on all nitrogen sources. IN was used as a parameter. Values at the nodes represent cophenic correlation coefficients. (B) Each square represents the growth of one strain in the PM wells supplied with the indicated L-histidine containing dipeptide, as a nitrogen source. The extent of growth was generated from the tetrazolium dye reduction during 96 h and represented by the intensity of coloration; white squares mean no growth and dark black squares mean abundant growth. Dipeptides are grouped respect to the N-terminus amino acid.[1].Bou Zeidan M, et al. L-histidine inhibits biofilm formation and FLO11-associated phenotypes in Saccharomyces cerevisiae flor yeasts. PLoS One. 2014 Nov 4;9(11):e112141.
  • L-histidine affects the growth of different S. cerevisiae strains in YPD rich medium. Tested strains (104 cells/mL) were incubated statically in 20% YPD for 48 h at 30°C, without (Ctrl) or with a serial dilution of L-histidine with concentrations range from 1 to 80 mM,. Dose-response curves show mean OD600 ± SD after 48 h of inoculation. S. cerevisiae flor strains are A9 (black circles), M23 (black triangles), V80 (grey down-pointing triangles), 3238-38 (white circles), 3238-32Δflo11 (grey circles) and S288c (black squares).[1].Bou Zeidan M, et al. L-histidine inhibits biofilm formation and FLO11-associated phenotypes in Saccharomyces cerevisiae flor yeasts. PLoS One. 2014 Nov 4;9(11):e112141.
  • Biofilm formation of flor strains is inhibited by L-histidine. (A) Biofilm formation at the air-liquid interface in 24-well microtiter plates for strains A9, M23, V80, 3238-32, 3238-32Δflo11 and S288c after 5 days of static incubation in 1.5 mL flor medium at 30°C in the absence (Ctrl) and presence of 10 mM of L-histidine (L-his) and L-histidine–containing dipeptides. The biofilm is visualized as opaque floating material at the top of each well. (B) Dry weight determinations of the biofilms formed by the strains in (A) without (Ctrl) and with treatment with 10 mM L-histidine and the L-histidine–containing dipeptides (as indicated). Data are means +SD of three replicate treatments. (C) CFU recovery after plating on YPD agar using serial dilutions of a duplicate of all the strains/L-histidine and strains/dipeptides combinations.[1].Bou Zeidan M, et al. L-histidine inhibits biofilm formation and FLO11-associated phenotypes in Saccharomyces cerevisiae flor yeasts. PLoS One. 2014 Nov 4;9(11):e112141.
Contact Us